Results 11 to 20 of about 22,799 (245)
Bleomycin in xeroderma pigmentosum [PDF]
A child with multiple squamous cell carcinomas associated with xeroderma pigmentosum (XP) was treated with Bleomycin on a twice weekly schedule utilizing a dosage of 30 mg/m2. Satisfactory clinical responses of facial and scalp lesions were observed. A total cumulative dose of 441 mg (630 mg/m2) was administered before fatal pulmonary toxicity occurred
Joan Short+2 more
openaire +4 more sources
The Role of Dermoscopy in Diagnosing Xeroderma Pigmentosum: A Practical Tool in Low-resource Settings [PDF]
is missing (Research letter)
Maëva Boyer+3 more
doaj +2 more sources
Xeroderma pigmentosum et dermoscopie
Le Xeroderma pigmentosum (XP) est une génodermatose rare, fréquente au Maghreb vu le taux élevé de mariage consanguin. Ses manifestations cutanées sont dominées par la fréquence de cancers cutanés.
Kawtar Inani, Fatimazahra Mernissi
doaj +3 more sources
Keratoplasty in Xeroderma Pigmentosum [PDF]
P. Sivasubramaniam
openaire +5 more sources
Porphyrin Metabolism in Xeroderma Pigmentosum*
H. El-Hefnawi, D.J. Cripps
openaire +4 more sources
Camouflage in xeroderma pigmentosum
Gayathri Krishnaswamy+3 more
doaj +4 more sources
Lung adenocarcinoma concomitant with xeroderma pigmentosum: a case report
Background Xeroderma pigmentosum is a rare, autosomal-recessive photosensitive dermatosis. Patients with xeroderma pigmentosum have an impaired ability to repair deoxyribonucleic acid damage caused by ultraviolet rays, resulting in skin cancer.
Masataka Matsumoto+2 more
doaj +1 more source
Xeroderma pigmentosum and acute myeloid leukemia: a case report
Background Xeroderma pigmentosum is a rare inherited disease characterized by extreme hypersensitivity to ultraviolet rays and predisposing to cutaneous malignancies that can appear in childhood.
H. Bencharef+7 more
doaj +1 more source